Update Reimbursement Scheme Jardiance®
From April 1, 2023, the use of Jardiance® (empagliflozin) in patients with chronic heart failure regardless of ejection fraction...
Update Reimbursement Fludrace®
The existing TBR for Fludrace® 62.50 micrograms has been expanded with the strength 31.25 micrograms. Because the health insurer...
Reimbursement Scheme Acecort®
The health insurer fully reimburses Acecort® 1, 2 and 3 mg as off March 1, 2023. The reimbursement by TBR Nederland will therefore...
Reimbursement Scheme Forxiga® (dapagliflozine) 10 mg for the treatment of HFpEF (LVEF >40%)
The health insurer does not yet fully reimburse Forxiga® (dapagliflozin) 10 mg for the treatment of HFpEF (LVEF >40%). The...
Reimbursement Scheme Isturisa®
The health insurer does not fully reimburse Isturisa® 1mg, 5mg and 10mg. The producer of this medicine has therefore asked TBR...
Select your medicine
Check your medicine expenses
Quickly check the maximum contribution you have to pay for your medicine